Media
2008-12-03
December 3, 2008
AllerGen Funding Renewed to 2012
AllerGen NCE Inc. has been successful in securing the balance of its initial seven years of Networks of Centres of Excellence (NCE) funding for the period 2009-2012!
As a result of the positive outcome of AllerGen’s mid-term review, AllerGen will continue to build upon its research investments and efforts to improve the prevention, control and treatment of allergic and related immune diseases.
AllerGen has successfully established a range of national and international partnerships with research, industry, health care and not-for-profit organizations. These partnerships have enabled translation of AllerGen’s research into economic and social benefits for Canadians.
Thanks goes out to everyone who contributed to the mid-term review, which took place on October 23, 1998 in Hamilton, as well as to Industry Canada and the Networks of Centres of Excellence Program.
Continued Government of Canada funding is recognition of AllerGen’s collective efforts and exemplary accomplishments in the field of asthma and allergic disease research and knowledge and technology exchange and exploitation.